Sunrise Medical ApS: Financial statements 2016
CVR: 37005665
Source: annual report 2016, Danish Business Authority
24/08/2015 – 30/06/2016
Sunrise Medical ApS (CVR 37005665) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK 6,384,137 and a net result of DKK -185,789. Equity in the 2016 report amounted to DKK -135,789.
- Gross Profit
- DKK 6,384,137
- Profit/Loss
- DKK -185,789
- Equity
- DKK -135,789
- Total Assets
- DKK 23,314,432
Official annual report
Find more companies like Sunrise Medical ApS
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2016
Sunrise Medical ApS has published its interim report for the period August 24, 2015 to June 30, 2016.
As of November 15, 2016, James Louis Barratt is registered as director of Sunrise Medical ApS.
As of November 15, 2016, Thomas Julius Rossnagel has stepped down as adm. dir. of Sunrise Medical ApS.
As of November 15, 2016, Robert Forman Smith has stepped down as director of Sunrise Medical ApS.
As of November 8, 2016, Peter Riley has joined the board of directors of Sunrise Medical ApS.
As of November 8, 2016, James Louis Barratt has joined the board of directors of Sunrise Medical ApS.
As of November 8, 2016, Thomas Julius Rossnagel has left the board of directors of Sunrise Medical ApS.
As of November 8, 2016, Robert Forman Smith has left the board of directors of Sunrise Medical ApS.
As of November 7, 2016, Peter Riley has left the board of directors of Sunrise Medical ApS.
About Sunrise Medical ApS
Sunrise Medical ApS is a Danish company of the type Anpartsselskab based in Taastrup, founded in 2015. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Adrian John Platt and James Louis Barratt. The board consists of Adrian John Platt (chair) and James Louis Barratt. The company is owned by Cidron Ollopa B.V.. The company has 22 employees (2026). In 2024, the company reported a gross profit of DKK 12,726,030 and a net result of DKK 1,921,194 compared with DKK 1,408,512 the year before. Equity in the 2024 report amounted to DKK 6,586,965.